Jessica Houang

Jessica Houang

Auto-generated profile, based on publicly available information

Jessica Houang

School of Science, Western Sydney University, Penrith, NSW 2750, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ABAlina Bekmukhametova
Alina Bekmukhametova
HRHerleen Ruprai
Herleen Ruprai
JHJames Hook
James Hook
DMDamia Mawad
Damia Mawad
JHJessica Houang
Jessica Houang
ALAntonio Lauto
Antonio Lauto
Infections caused by drug-resistant pathogens are rapidly increasing in incidence and pose an urgent global health concern. New treatments are needed to address this critical situation while preventing further resistance acquired by the pathogens. One promising approach is antimicrobial photodynamic therapy (PDT), a technique that selectively damages pathogenic cells through reactive oxygen species (ROS) that have been deliberately produced by light-activated chemical reactions via a photosensitiser. There are currently some limitations to its wider deployment, including aggregation, hydrophobicity, and sub-optimal penetration capabilities of the photosensitiser, all of which decrease the production of ROS and lead to reduced therapeutic performance. In combination with nanoparticles, however, these challenges may be overcome. Their small size, functionalisable structure, and large contact surface allow a high degree of internalization by cellular membranes and tissue barriers. In this review, we first summarise the mechanism of PDT action and the interaction between nanoparticles and the cell membrane. We then introduce the categorisation of nanoparticles in PDT, acting as nanocarriers, photosensitising molecules, and transducers, in which we highlight their use against a range of bacterial and fungal pathogens. We also compare the antimicrobial efficiency of nanoparticles to unbound photosensitisers and examine the relevant safety considerations. Finally, we discuss the use of nanoparticulate drug delivery systems in clinical applications of antimicrobial PDT.

3 April 2019 in Advanced Science
Verified
Journal Article
Open access
PDF file
ASAshour Sliow
Ashour Sliow
ZMZhi Ma
Zhi Ma
GGGaetano Gargiulo
Gaetano Gargiulo
DMDavid Anthony Mahns
David Anthony Mahns
DMDamia Mawad
Damia Mawad
ALAntonio Lauto
Antonio Lauto
An original wireless stimulator for peripheral nerves based on a metal loop (diameter ≈1 mm) that is powered by a transcranial magnetic stimulator (TMS) and does not require circuitry components is reported. The loop can be integrated in a chitosan scaffold that functions as a graft when applied onto transected nerves (graft‐antenna). The graft‐antenna is bonded to rat sciatic nerves by a laser without sutures; it does not migrate after implantation and is able to trigger steady compound muscle action potentials for 12 weeks (CMAP ≈1.3 mV). Eight weeks postoperatively, axon regeneration is facilitated in transected nerves that are repaired with the graft‐antenna and stimulated by the TMS for 1 h per week. The graft‐antenna is an innovative and minimally‐invasive device that functions concurrently as a wireless stimulator and adhesive scaffold for nerve repair.

1 January 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
HRHerleen Ruprai
Herleen Ruprai
ASAnu Shanu
Anu Shanu
DMDamia Mawad
Damia Mawad
JHJames Hook
James Hook
KKKristopher Kilian
Kristopher Kilian
ALAntonio Lauto
Antonio Lauto

16 August 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
HRHerleen Ruprai
Herleen Ruprai
SRSara Romanazzo
Sara Romanazzo
JIJake Ireland
Jake Ireland
KKKristopher Kilian
Kristopher Kilian
DMDamia Mawad
Damia Mawad
ALAntonio Lauto
Antonio Lauto

1 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MUMir Muhammad Nasir Uddin
Mir Muhammad Nasir Uddin
ABAlina Bekmukhametova
Alina Bekmukhametova
AAAnu Antony
Anu Antony
SBShital K. Barman
Shital K. Barman
JHJessica Houang
Jessica Houang
ALAntonio Lauto
Antonio Lauto
Cancer, a prominent cause of death, presents treatment challenges, including high dosage requirements, drug resistance, poor tumour penetration and systemic toxicity in traditional chemotherapy. Photodynamic therapy, using photosensitizers like rose bengal (RB) with a green laser, shows promise against breast cancer cells in vitro. However, the hydrophilic RB struggles to efficiently penetrate the tumour site due to the unique clinical microenvironment, aggregating around rather than entering cancer cells. In this study, we have synthesized and characterized RB-encapsulated chitosan nanoparticles with a peak particle size of ~200 nm. These nanoparticles are readily internalized by cells and, in combination with a green laser (λ = 532 nm) killed 94–98% of cultured human breast cancer cells (MCF-7) and prostate cancer cells (PC3) at a low dosage (25 μg/mL RB-nanoparticles, fluence ~126 J/cm2, and irradiance ~0.21 W/cm2). Furthermore, these nanoparticles are not toxic to cultured human normal breast cells (MCF10A), which opens an avenue for translational applications.

11 December 2017 in Journal of Biophotonics
Verified
Journal Article
Closed access
PDF file
JHJessica Houang
Jessica Houang
GPGabriel Perrone
Gabriel Perrone
DMDamia Mawad
Damia Mawad
Philip C. BoughtonPhilip C. Boughton
Philip C. Boughton
ARAndrew J. Ruys
Andrew J. Ruys
ALAntonio Lauto
Antonio Lauto